SignalHF vs physIQ Heart Rhythm and Respiratory Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Implicity
VS

AI Verdict

SignalHF is specifically designed to predict heart failure hospitalizations within 30 days by analyzing data from cardiac implantable electronic devices. In contrast, physIQ's module utilizes continuous wearable biosensor data to detect subtle physiological changes, including heart rhythm abnormalities and respiration rate, for broader early decompensation detection. While both leverage AI for cardiac health insights and early intervention, their distinct data sources and specific predictive targets make them suitable for different clinical applications.

Choose SignalHF if…

Choose SignalHF if your primary objective is to proactively reduce heart failure hospitalizations among patients with cardiac implantable electronic devices (CIEDs). This FDA-cleared AI algorithm is specifically designed to analyze CIED data, providing a 30-day prediction of hospitalization risk to enable timely, targeted interventions.

View SignalHF →

Choose physIQ Heart Rhythm and Respiratory Module if…

Choose physIQ Heart Rhythm and Respiratory Module if you need continuous, personalized physiological monitoring using wearable biosensors across a broader patient population. This platform excels at establishing individual baselines and detecting subtle changes in heart rhythm (including atrial fibrillation) and respiration rate, offering early insights into various signs of decompensation.

View physIQ Heart Rhythm and Respiratory Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature SignalHF physIQ Heart Rhythm and Respiratory Module
Pricing Contact for pricing Contact for pricing
Deployment SaaS Cloud-based platform
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SignalHF

SignalHF explicitly highlights features like automatic alerts for care teams, a unified platform for centralizing cardiac implantable device data, and AI-driven alert management to filter relevant events. These capabilities directly enhance usability by streamlining workflows and reducing alert fatigue for clinicians. While physIQ focuses on powerful data collection and analytics, its description does not detail specific user-facing workflow improvements.

Clinical Value

SignalHF

SignalHF offers a highly specific and impactful clinical value by predicting heart failure hospitalizations within 30 days using FDA-cleared AI, enabling proactive intervention and personalized care. While physIQ provides broad continuous physiological monitoring and detection of various conditions like atrial fibrillation and respiratory rate, SignalHF's focused predictive capability addresses a critical and costly clinical challenge directly.

Pricing & Value

Tie

Both tools explicitly state 'contact for pricing,' and neither provides any specific details regarding their cost structure or value propositions beyond their core features. Without transparent pricing or comparative value metrics, it is impossible to distinguish between them on this dimension.

Enterprise Readiness

physIQ Heart Rhythm and Respiratory Module

PhysIQ explicitly markets itself as an 'industry-leading, enterprise-ready cloud platform,' directly addressing this dimension. While SignalHF's SaaS deployment and unified platform for centralizing CIED data suggest strong enterprise capabilities, physIQ's explicit claim provides a stronger indication of its readiness for large-scale organizational adoption.

Innovation

physIQ Heart Rhythm and Respiratory Module

PhysIQ demonstrates greater innovation through its core AI-based personalized physiology analytics that learn individual patient baselines from continuous wearable biosensor data. This ability to detect subtle, individualized physiological changes for early decompensation across various conditions represents a more fundamental and broadly applicable advancement in digital medicine. SignalHF's predictive AI for HF hospitalizations from CIED data is also innovative but more narrowly focused.

Support & Docs

SignalHF

Implicity clearly outlines a comprehensive support structure, including a Customer Success team, dedicated Customer Success Managers, responsive expert support, and targeted training sessions for users. In contrast, the available information for physIQ does not detail its customer support or documentation offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature SignalHF physIQ Heart Rhythm and Respiratory Module
Name SignalHF physIQ Heart Rhythm and Respiratory Module
Company Implicity physIQ
Primary Predictive/Analytical Focus Predicts heart failure hospitalizations within 30 days AI-based personalized physiology analytics; detects subtle physiological changes and early signs of decompensation
Data Sources Analyzed Data from various cardiac implantable electronic devices (CIEDs), physiological data, demographics, lead measurements, episodes, and therapies Continuous wearable biosensor data
Key Detections/Alerts Generates automatic alerts for care teams based on risk scores for heart failure prediction; AI-driven alert management Calculates heart rate and heart rate variability, detects atrial fibrillation, determines respiration rate
Specialties Supported Cardiology Cardiology, Critical Care, Pulmonology

Videos

Demos, reviews, and walkthroughs featuring SignalHF and physIQ Heart Rhythm and Respiratory Module.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

SignalHF is an FDA-cleared AI algorithm designed to predict heart failure hospitalizations within 30 days by analyzing data from cardiac implantable electronic devices (CIEDs). physIQ Heart Rhythm and Respiratory Module focuses on generating unprecedented health insight using continuous wearable biosensor data and advanced analytics, detecting subtle physiological changes and early signs of decompensation, including atrial fibrillation and respiration rate.
SignalHF analyzes physiological data, demographics, lead measurements, episodes, and therapies from various manufacturer-agnostic cardiac implantable electronic devices (CIEDs) like pacemakers, ICDs, and CRTs. physIQ Heart Rhythm and Respiratory Module continuously collects and processes data from any wearable biosensor, utilizing AI-based personalized physiology analytics.
SignalHF specifically predicts heart failure hospitalizations within 30 days. physIQ Heart Rhythm and Respiratory Module calculates heart rate and heart rate variability, detects atrial fibrillation, and determines respiration rate, while also identifying early signs of decompensation by learning individual patient baselines.
SignalHF generates automatic alerts for care teams based on risk scores for heart failure hospitalization and offers AI-driven alert management to filter and highlight relevant events. physIQ Heart Rhythm and Respiratory Module detects subtle physiological changes and early signs of decompensation, implying that these insights are provided to care teams for intervention, though specific 'alert' mechanisms are not detailed in its description.
SignalHF is intended for qualified healthcare professionals managing patients over 18 years old who are receiving physiological monitoring for heart failure surveillance and are implanted with compatible cardiac implantable electronic devices. physIQ Heart Rhythm and Respiratory Module is for use in adult patients in subacute clinical and nonclinical settings for remote patient monitoring, particularly those who can wear biosensors for continuous monitoring across specialties like cardiology, critical care, and pulmonology.
SignalHF offers manufacturer-agnostic compatibility with various CIEDs, including pacemakers, ICDs, and CRTs from companies like Biotronik, Boston Scientific, and Medtronic. physIQ's platform continuously collects and processes data from any wearable biosensor, specifically mentioning compatibility with FDA-cleared, chest-worn biosensors using 'wet electrode' technology for single-lead ECG and triaxial accelerometer data.

Backers

Who funded each tool's parent company.

SignalHF

AI Tool Finder
AI-powered search. Results may not be comprehensive.